These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12009003)

  • 1. Protocols for identifying drug-nutrient interactions in patients: the role of the dietitian.
    Sanford MG; Ryan C; Cummings AD; Hunt A; Hackes B
    J Am Diet Assoc; 2002 May; 102(5):729-30; discussion 730-1. PubMed ID: 12009003
    [No Abstract]   [Full Text] [Related]  

  • 2. Carnitine deficiency associated with anticonvulsant therapy.
    Rodriguez-Segade S; de la Peña CA; Tutor JC; Paz JM; Fernandez MP; Rozas I; Del Río R
    Clin Chim Acta; 1989 May; 181(2):175-81. PubMed ID: 2500272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum carnitine levels in ambulatory epilepsy outpatients.
    Drake ME; Reider CR; Kay A
    Seizure; 1996 Dec; 5(4):251-3. PubMed ID: 8952008
    [No Abstract]   [Full Text] [Related]  

  • 4. Carnitine deficiency during valproic acid treatment.
    Van Wouwe JP
    Int J Vitam Nutr Res; 1995; 65(3):211-4. PubMed ID: 8830002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weight gain associated with valproate in childhood.
    Demir E; Aysun S
    Pediatr Neurol; 2000 May; 22(5):361-4. PubMed ID: 10913727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproate-induced hyperacute hyperammonemic coma in a patient with hypocarnitinemia.
    Sofi A; Herial NA; Ali II
    Am J Ther; 2013; 20(6):e703-5. PubMed ID: 20224318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of carnitine supplementation during valproic acid therapy.
    Raskind JY; El-Chaar GM
    Ann Pharmacother; 2000 May; 34(5):630-8. PubMed ID: 10852092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of valproic acid and carbamazepine treatment on serum biotin and zinc levels and on biotinidase activity.
    Castro-Gago M; Pérez-Gay L; Gómez-Lado C; Castiñeiras-Ramos DE; Otero-Martínez S; Rodríguez-Segade S
    J Child Neurol; 2011 Dec; 26(12):1522-4. PubMed ID: 21642615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Edema associated with valproate therapy.
    Basel-Vanagaite L; Zeharia A; Amir J; Mimouni M
    Ann Pharmacother; 1999 Dec; 33(12):1370-1. PubMed ID: 10630841
    [No Abstract]   [Full Text] [Related]  

  • 10. [Acute Intermittent porphyria and valproic acid].
    Noval Menéndez J; Campoamor MT; Laborda B; López-Colina G
    Rev Clin Esp; 2012 Apr; 212(4):217-8. PubMed ID: 22112281
    [No Abstract]   [Full Text] [Related]  

  • 11. Do epileptic children treated with valproate have a risk of excessive weight gain?
    Bosnak M; Dikici B; Haspolat K; Dagli A; Dikici S
    J Child Neurol; 2003 Apr; 18(4):306; author reply 306. PubMed ID: 12760438
    [No Abstract]   [Full Text] [Related]  

  • 12. Valproate-induced proximal renal tubular dysfunction: clinically relevant in the severely disabled epileptic population.
    Jaffe SL; Sanford M
    Epilepsia; 2005 Apr; 46(4):599-600. PubMed ID: 15816962
    [No Abstract]   [Full Text] [Related]  

  • 13. [Correlation between renal tubular dysfunction and serum carnitine deficiency in cases with valproate therapy].
    Ono H
    No To Hattatsu; 2009 Sep; 41(5):363-5. PubMed ID: 19764458
    [No Abstract]   [Full Text] [Related]  

  • 14. A case of chronic pancreatic insufficiency due to valproic acid in a child.
    Cooper MA; Groll A
    Can J Gastroenterol; 2001 Feb; 15(2):127-30. PubMed ID: 11240383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyperammonaemic encephalopathy due to valproic acid in the neonatal period].
    Jiménez-Parrilla F; Pérez-Sánchez A; Núñez-Solís JM; Madruga-Garrido M; Losada-Martínez A
    Rev Neurol; 2009 Jun 1-15; 48(11):613-4. PubMed ID: 19472163
    [No Abstract]   [Full Text] [Related]  

  • 16. Carnitine deficiency and hyperammonemia associated with valproic acid therapy.
    Ohtani Y; Endo F; Matsuda I
    J Pediatr; 1982 Nov; 101(5):782-5. PubMed ID: 6813444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ammonia and carnitine concentrations in children treated with sodium valproate compared with other anticonvulsant drugs.
    Thom H; Carter PE; Cole GF; Stevenson KL
    Dev Med Child Neurol; 1991 Sep; 33(9):795-802. PubMed ID: 1936631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gaze-evoked nystagmus associated with valproic acid-induced lamotrigine toxicity.
    Jung I; Shin JH; Kim J
    Clin Neurol Neurosurg; 2020 Sep; 196():106013. PubMed ID: 32623210
    [No Abstract]   [Full Text] [Related]  

  • 19. [The contribution of magnetic resonance imaging to the diagnosis of type I glutaric aciduria].
    González-Granado LI
    Rev Neurol; 2009 Jan 1-15; 48(1):56. PubMed ID: 19145572
    [No Abstract]   [Full Text] [Related]  

  • 20. Factor VII deficiency associated with valproate treatment.
    Unalp A; Dirik E; Kurul S
    Pediatr Int; 2008 Jun; 50(3):403-5. PubMed ID: 18533961
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.